Quality of Life Research

, Volume 20, Issue 6, pp 825–832 | Cite as

Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States

Article

Abstract

Purpose

To examine and quantify, at the US national level, the marginal differences in health-related quality of life (HRQoL) of diabetic patients with and without macrovascular comorbid conditions (MaVCC).

Methods

Using the pooled Medical Expenditure Panel Survey (MEPS) 2001 and 2003 data, a nationally representative community-dwelling adult sample (age ≥ 18) was included in the study. HRQoL measures included the preference-based EQ-5D index, Euroqol visual analogue scale (EQ-VAS), SF-12 physical component summary (PCS), and SF-12 mental component summary (MCS). Given the censored distribution of the data, a two-part model was used to identify the relationship between MaVCC and the EQ-5D index after controlling for age, sex, race, ethnicity, education, income, employment status, health insurance, smoking status, diabetes severity, and comorbidities. Censored least absolute deviation and ordinary least square models were employed to analyze EQ-VAS and SF-12 PCS/MCS, respectively.

Results

Compared to diabetic patients without MaVCC (N = 2431), those with MaVCC (N = 747) had significantly lower EQ-5D index (−0.062), EQ-VAS (−9.2), SF-12 PCS (−5.0), and MCS (−2.1) after controlling for differences in sociodemographics, smoking status, diabetes severity, and comorbidities (all P < 0.001).

Conclusions

MaVCC is consistently associated with lower HRQoL for patients with diabetes in the United States. Results of this study are valuable for future comparative-effectiveness and cost-effectiveness analyses in diabetes.

Keywords

Diabetes Health-related quality of life Cardiovascular disease EQ-5D 

Abbreviations

AHRQ

Agency for Healthcare Research and Quality

CCCs

Clinical classification categories

CLAD

Censored least absolute deviations estimator

EQ-VAS

Euroqol visual analogue scale

HRQoL

Health-related quality of life

HUI-3

Health Utilities Index Mark 3

MaVCC

Macrovascular comorbid conditions

MCS

Mental component summary

MEPS

Medical Expenditure Panel Survey

OLS

Ordinary least square

PCS

Physical component summary

QALYs

Quality-adjusted life years

QWB-SA

Self-Administered Quality of Well Being

Notes

Acknowledgments

This study was supported by a research grant from Merck & Co., Inc., Whitehouse Station, New Jersey, USA.

References

  1. 1.
    American Diabetes Association. (2009). Diabetes statistics. Available from http://www.diabetes.org/diabetes-basics/diabetes-statistics/. Accessed December 23, 2009.
  2. 2.
    American Diabetes Association. (2008). Economic costs of diabetes in the US in 2007. Diabetes Care, 31, 596–615.CrossRefGoogle Scholar
  3. 3.
    Saydah, S. H., Fradkin, J., & Cowie, C. C. (2004). Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA, 291, 335–342.PubMedCrossRefGoogle Scholar
  4. 4.
    Centers for Disease Control and Prevention. (2004). Prevalence and incidence. 1999 Diabetes Surveillance Report. Atlanta, GA: U.S. Department of Health and Human Services.Google Scholar
  5. 5.
    Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K., & Laakso, M. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine, 339, 229–234.PubMedCrossRefGoogle Scholar
  6. 6.
    Saydah, S. H., Miret, M., Sung, J., Varas, C., Gause, D., & Brancati, F. L. (2001). Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care, 24, 1397–1402.PubMedCrossRefGoogle Scholar
  7. 7.
    Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. New England Journal of Medicine, 334, 835–840.PubMedCrossRefGoogle Scholar
  8. 8.
    U. S. Department of Health and Human Services. (2000). Healthy people 2010 (2nd ed.). Washington, DC: U.S. Government Printing Office.Google Scholar
  9. 9.
    Brown, D. W., Balluz, L. S., Giles, W. H., et al. (2004). Diabetes mellitus and health-related quality of life among older adults. Findings from the behavioral risk factor surveillance system (BRFSS). Diabetes Research and Clinical Practice, 65, 105–115.PubMedCrossRefGoogle Scholar
  10. 10.
    Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43, 736–749.PubMedCrossRefGoogle Scholar
  11. 11.
    Manuel, D. G., & Schultz, S. E. (2004). Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care, 27, 407–414.PubMedCrossRefGoogle Scholar
  12. 12.
    UK Prospective Diabetes Study Group. (1999). Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care, 22, 1125–1136.CrossRefGoogle Scholar
  13. 13.
    Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22, 340–349.PubMedGoogle Scholar
  14. 14.
    Maddigan, S. L., Feeny, D. H., Majumdar, S. R., Farris, K. B., & Johnson, J. A. (2006). Understanding the determinants of health for people with type 2 diabetes. American Journal of Public Health, 96, 1649–1655.PubMedCrossRefGoogle Scholar
  15. 15.
    Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E., Wolffenbuttel, B. H., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care, 25, 458–463.PubMedCrossRefGoogle Scholar
  16. 16.
    Coffey, J. T., Brandle, M., Zhou, H., et al. (2002). Valuing health related quality of life in diabetes. Diabetes Care, 25, 2238–2243.PubMedCrossRefGoogle Scholar
  17. 17.
    Brown, G. C., Brown, M. M., Sharma, S., Brown, H., Gozum, M., & Denton, P. (2000). Quality of life associated with diabetes mellitus in an adult population. Journal of Diabetes and Its Complications, 14, 18–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Wexler, D. J., Grant, R. W., Wittenberg, E., et al. (2006). Correlates of health-related quality of life in type 2 diabetes. Diabetologia, 49, 1489–1497.PubMedCrossRefGoogle Scholar
  19. 19.
    Fu, A. Z. (2009). EuroQol (EQ-5D). In M. W. Kattan (Ed.), Encyclopedia of medical decision making (pp. 455–457). Thousand Oaks, CA: Sage Publications.Google Scholar
  20. 20.
    Berger, M. L., Bingefors, K., Hedblom, E. C., Pashos, C. L., & Torrance, G. W. (2003). Health care cost, quality, and outcomes: ISPOR book of terms. Lawrenceville, NJ: International Society for Pharmoeconomics and Outcomes Research.Google Scholar
  21. 21.
    Weights and response rates for the self-administered questionnaire. (2005). MEPS HC-079: 2003 full year consolidated data file (pp. c123–c124). Rockville, MD: Agency for Healthcare Research and Quality.Google Scholar
  22. 22.
    Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43, 203–220.PubMedCrossRefGoogle Scholar
  23. 23.
    Ware, J. E., Jr., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). How to score version 2 of the SF-12 (r) health survey. Lincoln, RI: Quality Metric, Inc.Google Scholar
  24. 24.
    Elixhauser, A., Steiner, C. A., & Whittington, C. A. (2000). Clinical classifications for health policy research: Hospital inpatient statistics, 1995. Healthcare cost and utilization project, HCUP-3 research note. Rockville, MD: Agency for Healthcare Research and Quality.Google Scholar
  25. 25.
    Comorbidity Software Version 3.4. (2009). Available from http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. Accessed February 28, 2009.
  26. 26.
    Fu, A. Z., & Kattan, M. W. (2006). Racial and ethnic differences in preference-based health status measure. Current Medical Research and Opinion, 22, 2439–2448.PubMedCrossRefGoogle Scholar
  27. 27.
    Li, L., & Fu, A. Z. (2009). Some methodological issues with the analysis of preference-based EQ-5D index score. Health Services and Outcomes Research Methodology, 9, 162–176.CrossRefGoogle Scholar
  28. 28.
    Sullivan, P. W., Ghushchyan, V. H., & Ben-Joseph, R. (2008). The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Quality of Life Research, 17, 1063–1071.PubMedCrossRefGoogle Scholar
  29. 29.
    Fu, A. Z., Qiu, Y., Radican, L., & Wells, B. J. (2009). Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care, 32, 2187–2192.PubMedCrossRefGoogle Scholar
  30. 30.
    Pischke, C. R., Weidner, G., Elliott-Eller, M., et al. (2006). Comparison of coronary risk factors and quality of life in coronary artery disease patients with versus without diabetes mellitus. American Journal of Cardiology, 97, 1267–1273.PubMedCrossRefGoogle Scholar
  31. 31.
    Luo, N., Johnson, J. A., & Coons, S. J. (2010). Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Medical Care, 48, 365–371.PubMedCrossRefGoogle Scholar
  32. 32.
    Farivar, S. S., Cunningham, W. E., & Hays, R. D. (2007). Correlated physical and mental health summary scores for the SF-36 and SF-12 health survey, V.1. Health and Quality of Life Outcomes, 5, 54.PubMedCrossRefGoogle Scholar
  33. 33.
    Centers for Disease Control and Prevention. (2002). National diabetes fact sheet: General information and national estimates on diabetes in the U.S., 2000. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of Quantitative Health SciencesCleveland ClinicClevelandUSA
  2. 2.Global Outcomes Research, Merck & Co., Inc.Whitehouse StationUSA
  3. 3.Department of Epidemiology and Public Health & Centre for Health Services Research, Yong Loo Lin School of MedicineNational University of SingaporeSingaporeSingapore

Personalised recommendations